YOUR BUSINESS AUTHORITY
Springfield, MO
Johnson & Johnson is predicting $2.5 billion in sales this year for its COVID-19 vaccine.
The company expects to produce up to 600 million doses of the one-shot vaccine this year. The previous goal was 1 billion shots.
The shot has faced production issues at a Baltimore plant run by J&J subcontractor Emergent BioSolutions Inc. Production was shut down after the U.S. Food and Drug Administration found sanitary problems and bad manufacturing practices, according to Reuters.
Read more from Reuters.
Alair Springfield is first Missouri franchise for Canada-based company.